Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Terns Pharmaceuticals Inc (TERN)

Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Insider Purchase: Chief Executive Officer of $TERN (TERN) Buys 15,450 Shares

Amy L. Burroughs, the Chief Executive Officer of $TERN ($TERN), bought 15,450 shares of the company on 12-05-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This...

TERN : 5.86 (-3.14%)
Terns Pharmaceuticals Announces Positive Early Data from Phase 1 CARDINAL Trial of TERN-701 for Chronic Myeloid Leukemia

TERN : 5.86 (-3.14%)
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

TERN : 5.86 (-3.14%)
Terns Pharmaceuticals Appoints Heather Turner to Board of Directors, Ann E. Taylor Steps Down

Terns Pharmaceuticals appoints Heather Turner to its Board of Directors, succeeding Ann Taylor after her three-year tenure.Quiver AI SummaryTerns Pharmaceuticals, Inc. has appointed Heather Turner, J.D.,...

TERN : 5.86 (-3.14%)
Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors

TERN : 5.86 (-3.14%)
Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate Updates

TERN : 5.86 (-3.14%)
Terns Pharmaceuticals to Participate in Upcoming November Investor Conferences

TERN : 5.86 (-3.14%)
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

TERN : 5.86 (-3.14%)
This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly's Weight-Loss Treatments

Terns has a modest market cap of less than $800 million, and its possible upside could be massive.

LLY : 767.76 (+1.35%)
GS : 566.10 (+2.19%)
TERN : 5.86 (-3.14%)
VKTX : 42.25 (+1.83%)
Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now.

Terns Pharmaceuticals just proved that it's competitive in the weight loss field.

VKTX : 42.25 (+1.83%)
TERN : 5.86 (-3.14%)

Barchart Exclusives

Elon Musk Didn't Expect Tesla or SpaceX to be Succesful, But He Did It Because They "Were Important Enough to do Anyway"
In a reflection on his entrepreneurial journey, tech magnate Elon Musk offered a glimpse into the mindset that led him to launch two of the world’s most groundbreaking ventures: Tesla and SpaceX. Speaking on his early years of founding these companies, Musk said, “I always have optimism, but I’m realistic.... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar